Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Revenue

Zhejiang Jiuzhou Pharmaceutical had revenue of 1.20B CNY in the quarter ending March 31, 2026, a decrease of -19.43%. This brings the company's revenue in the last twelve months to 5.22B, up 0.85% year-over-year. In the year 2025, Zhejiang Jiuzhou Pharmaceutical had annual revenue of 5.51B with 6.74% growth.

• Revenue (ttm): 5.22B
• Revenue Growth: +0.85%
• P/S Ratio: 2.23
• Revenue / Employee: 1.09M
• Employees: 4,791
• Market Cap: 11.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.51B	348.01M	6.74%
Dec 31, 2024	5.16B	-362.83M	-6.57%
Dec 31, 2023	5.52B	78.31M	1.44%
Dec 31, 2022	5.45B	1.38B	34.01%
Dec 31, 2021	4.06B	1.42B	53.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error